We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
1651
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.71M | ﹤0.01% |
29,843
+699
| +2% | +$61.5K |
|
1652
Prothena Corp
PRTA
$450M
| $2.71M | ﹤0.01% |
55,844
+6,126
| +12% | +$324K |
|
1653
Kratos Defense & Security Solutions
KTOS
$11.4B
| $2.7M | ﹤0.01% |
200,193
+6,838
| +4% | +$81.5K |
|
1654
TG Therapeutics
TGTX
$7.62B
| $2.7M | ﹤0.01% |
179,420
+8,117
| +5% | +$123K |
|
1655
Beam Therapeutics
BEAM
$2.84B
| $2.69M | ﹤0.01% |
87,948
+1,408
| +2% | +$55.6K |
|
1656
BridgeBio Pharma
BBIO
$16.5B
| $2.69M | ﹤0.01% |
162,387
+4,448
| +3% | +$51.9K |
|
1657
Zillow
ZG
$7.63B
| $2.68M | ﹤0.01% |
61,348
-1,098
| -2% | -$45.7K |
|
1658
Schneider National
SNDR
$6.25B
| $2.68M | ﹤0.01% |
100,078
+2,901
| +3% | +$78.2K |
|
1659
Marqeta
MQ
$1.66B
| $2.68M | ﹤0.01% |
146,413
+3,637
| +3% | +$81.2K |
|
1660
BGC Group
BGC
$4.89B
| $2.67M | ﹤0.01% |
510,880
+15,974
| +3% | +$73.2K |
|
|
ARCH
1661
DELISTED
Arch Resources, Inc.
ARCH
| $2.67M | ﹤0.01% |
20,270
+3
| +0% | +$434 |
|
1662
Green Dot
GDOT
$745M
| $2.66M | ﹤0.01% |
154,991
+5,826
| +4% | +$102K |
|
1663
Tronox
TROX
$1.04B
| $2.66M | ﹤0.01% |
185,069
+4,062
| +2% | +$62.6K |
|
1664
Celldex Therapeutics
CLDX
$3.28B
| $2.66M | ﹤0.01% |
73,924
+2,016
| +3% | +$87K |
|
1665
TriCo Bancshares
TCBK
$1.83B
| $2.66M | ﹤0.01% |
63,875
+793
| +1% | +$38.2K |
|
1666
Gogo Inc
GOGO
$492M
| $2.65M | ﹤0.01% |
183,063
+7,152
| +4% | +$112K |
|
1667
QuinStreet
QNST
$1.21B
| $2.65M | ﹤0.01% |
166,868
+9,398
| +6% | +$149K |
|
|
HPP
1668
Hudson Pacific Properties
HPP
$779M
| $2.64M | ﹤0.01% |
56,637
+3,366
| +6% | +$216K |
|
1669
PennyMac Financial
PFSI
$4.02B
| $2.63M | ﹤0.01% |
44,122
-708
| -2% | -$43.8K |
|
|
CSII
1670
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.62M | ﹤0.01% |
132,048
+6,995
| +6% | +$121K |
|
1671
Mesa Laboratories
MLAB
$574M
| $2.61M | ﹤0.01% |
14,929
+902
| +6% | +$162K |
|
1672
Veracyte
VCYT
$3.8B
| $2.61M | ﹤0.01% |
116,865
+1,901
| +2% | +$45.9K |
|
|
INN
1673
Summit Hotel Properties
INN
$700M
| $2.6M | ﹤0.01% |
371,975
+17,216
| +5% | +$131K |
|
1674
Krystal Biotech
KRYS
$9.66B
| $2.6M | ﹤0.01% |
32,469
+635
| +2% | +$49.9K |
|
1675
BioCryst Pharmaceuticals
BCRX
$2.4B
| $2.59M | ﹤0.01% |
311,069
+2,538
| +0.8% | +$24.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.